Drug-labels.com

Reminyl ER: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
8 mg, 16 mg, 24 mg

Patient Medication Information: uses, side effects, how to take - Reminyl ER

ABOUT THIS MEDICATION

What the medication is used for:

REMINYL® ER is used to treat the symptoms of mild to moderate Alzheimer’s disease (a type of dementia), a disease that alters brain function. Alzheimer’s disease causes increasing memory loss, confusion and behavioural changes, which make it increasingly difficult to carry out normal daily activities.

This medication should only be taken after proper diagnosis of your condition has been made by your doctor.

What it does:

This medication is one of a group of drugs called “cholinesterase inhibitors” which are used to treat the symptoms of mild to moderate Alzheimer’s disease. Dementia due to Alzheimer’s disease is believed to be related to lack of a substance in the brain called acetylcholine, a substance which is thought to be necessary for good brain function. REMINYL® ER increases the amount of this substance in the brain, improving memory.

When it should not be used:

Do not use REMINYL® ER if you/the person you are caring for:

  • are/is allergic to galantamine hydrobromide or to any non-medicinal ingredient in the formulation
  • have/has ever had an allergic reaction to a similar type of medicine
  • are/is a child under 18 years of age

What the medicinal ingredient is:

galantamine hydrobromide

What the nonmedicinal ingredients are:

REMINYL® ER extended release capsules: Gelatin, diethyl phthalate, ethylcellulose, hypromellose, polyethylene glycol, titanium dioxide and sugar spheres (sucrose and starch). The 16 mg capsule also contains red ferric oxide. The 24 mg capsule also contains red ferric oxide and yellow ferric oxide.

What dosage forms it comes in:

Extended release capsules: 8 mg, 16 mg, 24 mg

WARNINGS AND PRECAUTIONS

BEFORE you use REMINYL® ER, talk to your doctor or pharmacist if you/the person you are caring for have, or had, any of the following:

  • heart condition
  • an ulcer or history of ulcers in the stomach or gut
  • a blockage of the stomach or in the gut
  • seizures [or fits] (such as epilepsy)
  • a respiratory disease that affects breathing (such as asthma or obstructive pulmonary disease)
  • problems passing urine
  • an increased risk of developing ulcers (for example, you are taking non-steroidal anti-inflammatory drugs (NSAIDs) or high doses of acetylsalicylic acid [ASA (Aspirin®)]
  • liver or kidney problems
  • pregnant or planning to become pregnant

  • breast-feeding or planning to breast-feed
  • having an operation with general anesthesia (medication that puts you to sleep)
  • taking any other medications, including prescription, over-the-counter, herbal medicines or natural health products

Talk to your doctor right away if you have any skin rashes or inflammation, blisters or swelling of the skin.

Also tell your doctor if you recently had an operation on the stomach, gut or bladder.

REMINYL® ER can cause weight loss. Your doctor will check your weight regularly while you are taking REMINYL® ER.

Driving and using machines: Your doctor will tell you whether your illness allows you to drive vehicles and use machines safely. REMINYL® ER may make you feel dizzy or sleepy, especially during the first few weeks of treatment. If REMINYL® ER affects you, do not drive or use any tools or machinery.

INTERACTIONS WITH THIS MEDICATION

Always tell your doctor, nurse or pharmacist if you are taking any other medicines, either prescription, over-the-counter, herbal medicines, or natural health products, because taking some medicines together can be harmful.

REMINYL® ER should not be used with medicines that work in a similar way.

The following may interact with REMINYL® ER:

  • anticholinergics (such as drugs for diarrhea, Parkinson’s disease, or airway spasms)
  • medicines taken for heart conditions or high blood pressure (such as digoxin or beta-blockers)
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or high doses of acetylsalicylic acid [ASA (Aspirin®)], which can increase the risk of ulcers
  • antidepressants (such as amitriptyline, fluoxetine, fluvoxamine or paroxetine)
  • ketoconazole (an antifungal)
  • erythromycin (an antibiotic)
  • quinidine (for irregular heart beat)

REMINYL® ER may affect some anesthetics. If you are going to have an operation under a general anesthetic, tell the doctor that you are taking REMINYL® ER, well in advance.

PROPER USE OF THIS MEDICATION

You will start treatment with REMINYL® ER at a low dose, and then slowly increase this to find the most suitable dose for you. Your doctor will explain what dose to start with and when the dose should be increased. If you are not sure what to do, or find the effect of REMINYL® ER is too strong or too weak, talk to your doctor or pharmacist.

Usual dose:

  • The usual starting dose is 8 mg, taken once a day.
  • Your doctor may gradually increase your dose, every 4 weeks or more, until you reach a dose that is suitable for you.
  • The maximum dose is 24 mg, taken once a day.
  • Take your dose of REMINYL® ER once a day in the morning, with water or other liquids. Try to take REMINYL® ER with food.

DO NOT take more than one capsule in a day unless instructed to by your doctor

If you have liver or kidney problems, your doctor may give you a reduced dose of REMINYL® ER, or may decide this medicine is not suitable for you.

While you are taking REMINYL® ER

Drink plenty of liquids, to keep yourself hydrated.

Your doctor will need to see you regularly, to check that this medicine is working and to discuss how you are feeling.

REMEMBER: This medicine is for you. Only a doctor can prescribe it for you. Never give it to someone else. It may harm them even if their symptoms appear to be similar to yours.

Overdose:

If you think you/the person you are caring for have/has taken too much REMINYL® ER, contact your doctor, nurse, pharmacist, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

The signs of overdose may include:

  • severe nausea and vomiting, abdominal cramps, sweating
  • weak muscles, difficulty breathing
  • seizures (fits)
  • low blood pressure, abnormal heart rhythm that may cause loss of consciousness

Missed dose:

If you forget to take a dose, do not worry, wait and take the next dose at the usual time. Do NOT take two doses at once.

If your treatment is interrupted for several days or longer, do NOT re-initiate treatment without contacting your doctor.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

If side effects occur, they are mainly experienced early in the treatment or when the dose is increased. Most tend to disappear gradually as the body adapts to the treatment; for example, nausea (feeling sick) and vomiting (being sick) generally pass after a few days. However, you should tell your doctor about any side effects, especially if they persist.

Other possible side effects include:

  • abdominal pain, diarrhea, indigestion, decreased appetite
  • difficulty swallowing
  • weight loss
  • flushing
  • dehydration (sometimes severe)
  • weakness
  • fever
  • malaise
  • leg cramps
  • muscle spasms
  • tingling in the hands or feet
  • ringing in the ears
  • headache
  • dizziness
  • blurred vision
  • tiredness, sleepiness or sleeplessness
  • depression
  • runny nose
  • sweating
  • urinary tract infection, incontinence
  • falling, sometimes resulting in injury
  • trembling
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor, nurse or pharmacistStop taking drug and seek immediate medical help
Only if severeIn all cases
Common
Behavioral Changes: agitation and aggression✓
Fainting✓
High Blood Pressure: headache, dizziness, vision problems, shortness of breath✓
Uncommon
Problems with Heart Rhythm: irregular beating of the heart✓
Heart Attack: pain or tightness in the chest✓
Seizures: fits or convulsions✓
Stroke: sudden weakness or numbness of the face, arms or legs, especially on one side, slurred speech or vision problems✓

Low Blood Pressure: dizziness, fainting, lightheadedness

may occur when you go from lying or sitting to standing up

✓
Severe confusion✓
Rare
Allergic Reaction: rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing✓
Thoughts of suicide or self-harm✓
Very Rare
Stomach ulcer and gastrointestinal hemorrhage: blood in the stools, black, tarry stools, or vomiting blood✓
UnknownLiver Disorder: yellowing of the skin or eyes, dark urine, abdominal pain, nausea, vomiting, loss of appetite✓
Decreased Levels of Potassium in the Blood: irregular heartbeats, muscle weakness and generally feeling unwell✓
Hallucinations: seeing, feeling or hearing things that are not there✓
Stevens-Johnson Syndrome: Severe rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals✓
Acute Generalized Exanthematous Pustulosis: Red rash covered with small pus-filled bumps that can spread over the body, sometimes with a fever✓
Erythema Multiforme: Rash that may blister, with spots that look like small targets✓

If you are caring for a patient with Alzheimer's disease who has new symptoms you should discuss them with his or her doctor.

If you feel unwell in the ways described in this section or any other way, or have any symptoms that you do not understand or find distressing, you should contact your doctor immediately. If you experience side effects that are severe, stop taking the drug and contact your doctor immediately.

This is not a complete list of side effects. For any unexpected effects while taking REMINYL® ER, contact your doctor or pharmacist.

HOW TO STORE IT

Store REMINYL® ER in a cool dry place between 15 to 30°C.

Keep out of the reach and sight of children.

Medicines can be kept for a limited period only. Therefore, do not use REMINYL® ER after the date (month and year) printed after “EXP”, even if it has been stored properly. Always return old medicines to your pharmacist.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program Health Canada Postal Locator 0701E Ottawa, Ontario K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect® Canada Web site at www.healthcanada.gc.ca/medeffect

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

For questions, concerns, or the full Product Monograph go to:

www.janssen.com/canada

or contact the manufacturer, Janssen Inc., at:

1-800-567-3331 or 1-800-387-8781.

Janssen Inc.

Toronto, Ontario M3C 1L9

Last revised: January 11, 2017

All trademarks used under license.

All other third party trademarks are trademarks of their respective owners.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02266717

Revision date stated in the text: January 11, 2017

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Reminyl ER

Rx or OTC
Prescription (Rx)?
DIN 02266717, 02266725, 02266733
Schedule(s) PRESCRIPTION
Active ingredient(s) Galantamine (galantamine hydrobromide)
Dosage form(s) Capsule (Extended-Release)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06D Anti-dementia drugs
        1. N06DA Anticholinesterase anti-dementia drugs
          1. N06DA04 Galantamine
Company JANSSEN INC
Current status Cancelled Post Market
Strengths and forms
DIN Strength Dosage form(s) Current status
02266717 8 MG Capsule (Extended-Release) Cancelled Post Market April 3, 2017
02266725 16 MG Capsule (Extended-Release) Cancelled Post Market March 31, 2017
02266733 24 MG Capsule (Extended-Release) Cancelled Post Market April 4, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.